What Does the Historical and Current Interventional Oncology Devices Market Size Trend Indicate?
The interventional oncology devices market has seen considerable growth due to a variety of factors.
• The market size for interventional oncology devices has seen significant expansion in the past few years, with projections indicating a rise from $2.39 billion in 2024 to $2.52 billion in 2025, presenting a Compound Annual Growth Rate (CAGR) of 5.3%.
Factors such as increasing age demographics, rising instances of cancer, enhanced expenditure on pharmaceutical research and development, and growth in healthcare spending and healthcare facilities have all contributed to the robust growth witnessed in the historic period.
How Will the Interventional Oncology Devices Market Size Evolve over the Forecast Period?
The interventional oncology devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for interventional oncology devices is predicted to experience significant expansion in the coming years, ballooning to $3.34 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%.
This surge in the projected period can be related to factors such as the rising elderly population, an escalating inclination towards minimally invasive surgeries (MIS), increased investment in research and development, healthcare expenditure growth, untapped potential in nascent economies, and a surge in cancer and chronic disease cases. Key trends during the forecast period encompass concentration on the creation of advanced image-guided oncology devices, harnessing artificial intelligence for developing pioneering devices, producing novel and inventive embolic devices for facilitating enhanced oncology procedures, emphasizing on the utilization of robotic technology, and fostering partnerships with other firms and research organizations to expedite product development and innovation.
Which Factors Are Boosting Growth In The Interventional Oncology Devices Market?
Several major businesses in the interventional oncology devices market are prioritizing technologies such as tissue volume to elevate the precision of diagnoses and the effectiveness of treatment in oncology procedures. The term tissue volume refers to the quantity of natural tissue accumulated during a biopsy procedure. More extensive tissue volumes can offer more thorough samples, which enhances diagnostic precision and the efficiency of treatment plans. For example, in June 2023, Argon Medical, a US-based medical device firm, introduced the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage has the capability to gather up to 35% more samples than its top rivals, which decreases the necessity for numerous passes during biopsies. This feature is vital for securing adequate tissue samples for precise diagnosis.
What Key Areas Define The Segmentation Of The Global Interventional Oncology Devices Market?
The interventional oncology devices market covered in this report is segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems
Pre-Book The Interventional Oncology Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Interventional Oncology Devices Market?
Leading businesses are prioritizing the implementation of robotics technology in interventional oncology devices to enhance efficiency. The robotic setup combines imagery-based planning and navigating along with the fitting of various tools to the appropriate body region, ensuring better accuracy and productivity. An example of this can be seen in Quantum Surgical's Epione interventional oncology robotics platform, which the U.S. Food and Drug Administration approved in March 2022.
Who Are the Key Players in the Interventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market include:
• Boston Scientific Corporation
• Terumo Corporation
• Siemens Healthineers
• Sirtex Medical Limited
• Henlius
• Viant Medical
• AngioDynamics Inc.
• Pfizer
• Steris Applied Sterilization Technologies
• Dr.Reddys
• CapeRay
• Innovent Biologics
• Novartis AG
• Consonance
• ABLbio
• Adimmune
• Heraeus Medical
• Bioavlee
• Mediceena International
• Sinapi biomedical
• Olympus
• Freudenberg Medical
• Hisun Pharma
• Beijing ShuangLu Pharmaceuticals
• Edwards LifeSciences Corp
• Gulf Dent Trading
• LifeTech Scientific Corporation
• Biomerics
• Medtronic plc
• Dickinson & Company
• 3M Company
• DISA Vascular
• Johnson & Johnson
• Eurolab
• Koninklijke Philips
• Quantum SurgicalKyowa Hakko Kirin
• Viatris
• Nipro
• Zimmer Biomet Holdings
• Profound Medical
• Gedeon Richter
• Baxter
• Ti-TaMED
• Abbott Laboratories
• Cook Medical LLC
• Adavium Medical
• Autocam Medical
• Bio-Thera
• Stryker
• GE Healthcare
• Sonic Healthcare
• Medicem
• HealthTronics
• Bayer AG
• Intuitive Surgical Inc
• Aster DM Healthcare
• Danaher Corporation
• Varian Medical Systems Inc.
• Smileneo
• EDAP TMS S.A
• Fresenius Medical Care AG
• China Regenerative Medicine International
What Is The Most Dominant Region In The Interventional Oncology Devices Market?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
